BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11824446)

  • 41. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study.
    Pelinck MJ; Vogel NE; Hoek A; Simons AH; Arts EG; Mochtar MH; Beemsterboer S; Hondelink MN; Heineman MJ
    Hum Reprod; 2006 Sep; 21(9):2375-83. PubMed ID: 16751647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Association between ovarian stimulation regime and protein metabolism of patients undergoing IVF/ICSI therapy].
    Hammadeh ME; Mauss V; Meisinger M; Herrmann W; Georg T; Rosenbaum P; Schmidt W
    Zentralbl Gynakol; 2003 May; 125(5):183-8. PubMed ID: 14556096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Consequences of stimulation on oocyte quality].
    Clément P
    Gynecol Obstet Fertil; 2007 Sep; 35(9):890-7. PubMed ID: 17822936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of IVF and ovulation induction.
    Klemetti R; Sevón T; Gissler M; Hemminki E
    Hum Reprod; 2005 Dec; 20(12):3293-300. PubMed ID: 16126753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scientific evidence shows the need for a fresh approach to IVF.
    Nargund G
    Womens Health (Lond); 2015 Jan; 11(1):11-3. PubMed ID: 25581050
    [No Abstract]   [Full Text] [Related]  

  • 49. [Controlled ovarian hyperstimulation in an in vitro fertilization program. Results and prevention of complications].
    Grochowski D
    Ginekol Pol; 2000 Oct; 71(10):1293-6. PubMed ID: 11143940
    [No Abstract]   [Full Text] [Related]  

  • 50. Prolonged ovarian hyperstimulation for poor responders in in-vitro fertilization treatment cycles.
    Ahmad G; Lewis-Jones DI; Gazvani R
    Int J Gynaecol Obstet; 2006 Aug; 94(2):141-2. PubMed ID: 16828769
    [No Abstract]   [Full Text] [Related]  

  • 51. [Short term complications of medically assisted reproduction techniques (besides pregnancy complications)].
    Hedon B; Dechaud H
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):181-5. PubMed ID: 9471456
    [No Abstract]   [Full Text] [Related]  

  • 52. Assisted reproduction techniques.
    Jones SV
    Br J Hosp Med; 1995 Jun 7-20; 53(11):570-4. PubMed ID: 7655755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acute hemorrhage during extracorporeal fertilization].
    Ocipenkova-Vichtomova TK; Platonova GA
    Sud Med Ekspert; 2012; 55(2):53-5. PubMed ID: 22686060
    [No Abstract]   [Full Text] [Related]  

  • 54. Association of blood group A with early-onset ovarian hyperstimulation syndrome.
    Binder H; Flegel WA; Emran J; Müller A; Dittrich R; Beckmann MW; Zingsem J; Eckstein R; Ringwald J
    Transfus Clin Biol; 2008 Dec; 15(6):395-401. PubMed ID: 18757223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infertility and thrombophilia.
    Grandone E
    Thromb Res; 2005 Feb; 115 Suppl 1():24-7. PubMed ID: 15790146
    [No Abstract]   [Full Text] [Related]  

  • 56. Does i.v. albumin prevent ovarian hyperstimulation syndrome?
    Koike T; Araki S; Ogawa S; Minakami H; Sato I
    Hum Reprod; 1999 Jul; 14(7):1920. PubMed ID: 10402419
    [No Abstract]   [Full Text] [Related]  

  • 57. From accepting oversight to being overlooked: the devilish details of controlled ovarian stimulation.
    Albertini DF
    J Assist Reprod Genet; 2021 Sep; 38(9):2225-2226. PubMed ID: 34585314
    [No Abstract]   [Full Text] [Related]  

  • 58. [Isolated and recurrent hydrothorax during ovarian stimulation].
    Pirrello O; Garbin O; Bettahar-Lebugle K; Nisand I
    Gynecol Obstet Fertil; 2000 May; 28(5):396-400. PubMed ID: 10893884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A child at all costs? At what price? Consequences for the mother].
    Belaisch-Allart J; Mayenga JM
    Contracept Fertil Sex; 1997 Apr; 25(4):279-84. PubMed ID: 9229517
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recommendations of good practice: medicines that induce ovulation (April 2004)].
    AFSSAPS
    Gynecol Obstet Fertil; 2004 Sep; 32(9):829-33. PubMed ID: 15508197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.